In response to events in Japan as a result of the Tohoku Kanto Earthquake and tsunami that devastated Japan's north east coastline region, GlaxoSmithKline (GSK) is supporting the ongoing relief efforts by working with the Japanese authorities,

Novartis has committed to providing the equivalent of over USD 3 million in immediate relief aid to the victims of the recent earthquake in Japan.

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) and Boehringer Ingelheim announced the signing of a biopharmaceutical manufacturing agreement for therapeutic antibodies.

Eli Lilly and Company (NYSE: LLY) has been named to the 2011 NAFE Top 50 Companies for Executive Women by the National Association for Female Executives (NAFE).

GlaxoSmithKline (GSK) announced positive, top-line results of the ADVANCE-Parkinson's Disease (PD) Phase III clinical study, conducted by Impax Pharmaceuticals, of IPX066 versus immediate-release (IR) carbidopa-levodopa (CD-LD) in advanced PD patients experiencing motor fluctuations.

Amgen (Nasdaq: AMGN) announced that the company will donate $1 million to Japanese disaster relief efforts. Amgen and the Amgen Foundation will distribute the funds to both Direct Relief International and International Medical Corps to bring basic needs and vital health services to those affected in Japan.

Abbott (NYSE: ABT), through its philanthropic foundation the Abbott Fund, is providing $3 million (245 million yen) to support immediate relief efforts in response to the devastating earthquake and tsunami in Japan.